"THIS HOUSE STRONGLY RECOMMENDS THE USE OF HPV VACCINATION AFTER INITIAL TREATMENT OF HPV GENITAL LESIONS"
FOR - Prof Elmar A Joura MD, Vienna
AGAINST - Mr Peter Greenhouse FRCOG, Bristol
CHAIR - Prof Colm O'Mahony, Chester
This debate is the traditional closing item of the annual congress of IUSTI-Europe - the International Union against Sexually Transmitted infections, European section {[ Ссылка ]) - held in Zagreb 11-14 September 2024. It focusses on the evidence for, and efficacy of HPV vaccination in the presence of active HPV infection as a possible adjunct to therapy.
In this situation, HPV vaccination has been shown to be prophylactic - i.e. preventing future infection or reinfection with additional HPV strain types - but the possibility of the vaccine having any therapeutic effect has been the subject of several Randomised Controlled Trials and systematic reviews, some of which are referenced in this debate.
IUSTI-Europe runs a serires of educational webinars discussing current topics across the entire field of STI - [ Ссылка ]
It is one of five geographical regions of IUSTI World - [ Ссылка ] - which is responsible for coordination of advisory public health policy, education and treatment guidelines.
We invite you to enjoy the debate & consider joining IUSTI - See links above.
